Stay updated on Idasanutlin Combo Therapy in AML Clinical Trial
Sign up to get notified when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.

Latest updates to the Idasanutlin Combo Therapy in AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page’s versioning information.SummaryDifference0.0%

- Check46 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3 on the Study Details page.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, along with a banner about government funding; these changes affect only site metadata and banners, not the study details.SummaryDifference0.3%

- Check82 days agoChange DetectedAn administrative notice about government funding and NIH operations status was added, and the revision label changed to v3.4.1 (v3.4.0 removed), which appears cosmetic and does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check89 days agoChange DetectedShow glossary now appears on the page; QC-related labels have been reformatted (Last Update Submitted that Met QC Criteria) and No FEAR Act Data capitalization adjusted. Revision updated from v3.3.4 to v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Idasanutlin Combo Therapy in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.